Clinical evaluation study: Bupropion versus Psychodynamic mental training according to Dr. Grohs for smoke withdrawal(Klinische Evaluierungsstudie: Bupropion versus Psychodynamisches Mentaltraining nach Dr. Grohs zur Raucherentwöhnung - Bupropion vs. PDM zur Raucherentwöhnung
- Conditions
- nicotine addiction
- Registration Number
- EUCTR2005-006189-32-AT
- Lead Sponsor
- Steiermärkische Gebietskrankenkasse
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
nicotine addiction
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
mental illness, psychiatric diagnosis (except nicotine or caffeine addiction)
for Zyban: idiosyncrasy, epilepsy, bulimia, anorexia, zirrhosis, simultanous intake of MAO-inhibitors, brain tumour, alcohol or sedatives detoxication, pregnancy, nursing.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method